Predicate Research Report · generated 2026-08-21 · Print / save as PDF · Save to account
DDC — Predicate Candidate Screening
13 FDA 510(k) clearances under this product code; the 50 most recent screened below.
45 daysmedian FDA review time
149 days90th percentile
13clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K023592 | SERAQUEST ANTI-THYROGLOBULIN | Quest Intl., Inc. | 2003-01-06 | 73 | 0 |
| K012208 | ACCESS THYROGLOBULIN ANTIBODY AND CALIBRATORS ON THE ACCESS | Beckman Coulter, Inc. | 2001-09-07 | 53 | 1 |
| K000363 | MODIFICATION TO ZEUS SCIENTIFIC, INC., THYROGLOBULIN IGG ELI | Zeus Scientific, Inc. | 2000-02-18 | 14 | 0 |
| K991610 | ZEUS SCIENTIFIC INC., TPO IGG ELISA TEST SYSTEM. | Zeus Scientific, Inc. | 1999-06-25 | 46 | 0 |
| K991179 | ZEUS SCIENTIFIC, INC., THYROGLOBULIN IGG ELISA TEST SYSTEM | Zeus Scientific, Inc. | 1999-06-17 | 71 | 0 |
| K971835 | ANTI-THYROGLOBULIN (TG) MICROPLATE ELISA | Monobind | 1997-07-03 | 45 | 0 |
| K953066 | SERODIA ATG | Fujirebio America, Inc. | 1995-08-14 | 45 | 0 |
| K943625 | AUTOSTAT II ANTI-THYROGLOBULIN | Cogent Diagnotics , Ltd. | 1994-12-22 | 149 | 0 |
| K936010 | THYROGLOBULIN AUTOANTIBODY ENZYME IMMUNOASSAY | Biomerica, Inc. | 1994-07-18 | 214 | 0 |
| K930486 | QUANTA LITE(TM) THYROID T ELISA | Inova Diagnostics, Inc. | 1993-03-15 | 45 | 0 |
| K865020 | SERA-TEK THYROGLOBULIN ANTIBODY TEST | Miles Laboratories, Inc. | 1987-02-02 | 41 | 0 |
| K780873 | THYMUNE-M | Burroughs Wellcome Co. | 1978-06-14 | 15 | 0 |
| K780874 | THYMUNE-T | Burroughs Wellcome Co. | 1978-06-14 | 15 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda